Skip to main content
Chiron Recombinant Proteins on Muck Rack

Chiron Recombinant Proteins

As seen in: Pharmaceutical Online, Bioprocess Online
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Chiron Recombinant

Contact Chiron Recombinant, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Recombinant Proteins: Understanding 5 Key Process Development Challenges

|
By Tom Stapp, Kelsey Gomez, Chiron Recombinant Proteins
| Pharmaceutical Online Verified
By Tom Stapp and Kelsey Gomez, Chiron Recombinant Proteins For many biotech companies, particularly those developing orphan or small-market drugs, process development is not the first thing on their mind. While they understand the importance of creating a scalable and repeatable process resistant to supply chain disruptions, the need to conceive a viable molecule takes precedence in early development.
Open in Who Shared Issue with article?

Recombinant Proteins: Understanding 5 Key Process Development Challenges

|
By Tom Stapp, Kelsey Gomez, Chiron Recombinant Proteins
| Bioprocess Online Verified
Article | October 21, 2022 By Tom Stapp and Kelsey Gomez, Chiron Recombinant Proteins For many biotech companies, particularly those developing orphan or small-market drugs, process development is not the first thing on their mind. While they understand the importance of creating a scalable and repeatable process resistant to supply chain disruptions, the need to conceive a viable molecule takes precedence in early development.
Open in Who Shared Issue with article?
See all 2 articles